We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Nyxoah Appoints Dr. Maurits S. Boon, MD as Chief Medical Officer Mont-Saint-Guibert, Belgium – April 11, 2024, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or...
Informations sur le nombre total de droits de vote et d'actions INFORMATION RÉGLEMENTÉE Informations sur le nombre total de droits de vote et d'actions Mont-Saint-Guibert (Belgique...
Nyxoah Fait Progresser sa Stratégie d'Accès aux Patients en Annonçant un Partenariat Stratégique avec l'American Association of Otolaryngology – Head & Neck Surgery Foundation...
Nyxoah Announces DREAM U.S. Pivotal Study Meets Primary Endpoints Nyxoah Announces DREAM U.S. Pivotal Study Meets Primary Endpoints Reports an Apnea-Hypopnea Index (AHI) responder rate of...
Nyxoah Publie ses Résultats Financiers et Opérationnels pour le Quatrième Trimestre et l'Exercice 2023 Nyxoah Publie ses Résultats Financiers et Opérationnels pour le Quatrième Trimestre...
Nyxoah to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference Mont-Saint-Guibert, Belgium – February 29, 2024, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext...
Nyxoah to Release Fourth Quarter and Financial Year 2023 Financial Results on March 5, 2024 Nyxoah to Release Fourth Quarter and Financial Year 2023 Financial Results on March 5, 2024...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.44 | 4.94382022472 | 8.9 | 10.35 | 8.6 | 26295 | 9.73478102 | DE |
4 | -3.46 | -27.03125 | 12.8 | 12.85 | 8.3 | 35831 | 9.93213047 | DE |
12 | 0.14 | 1.52173913043 | 9.2 | 17.6 | 8.3 | 55532 | 12.2532555 | DE |
26 | 3.44 | 58.3050847458 | 5.9 | 17.6 | 3.79 | 46131 | 9.4932469 | DE |
52 | 1.48 | 18.8295165394 | 7.86 | 17.6 | 3.79 | 24724 | 9.28133581 | DE |
156 | -10.3 | -52.4439918534 | 19.64 | 30 | 3.79 | 15057 | 11.72972672 | DE |
260 | -10.66 | -53.3 | 20 | 30 | 3.79 | 14886 | 12.68924123 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions